A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug as a Radiosensitizer in Patients With Advanced Breast Cancer Brain Metastasis.
Clinical trial NCT06839547 · RECRUITING
Trial details
- NCT number
- NCT06839547
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-03-01
- Primary completion
- 2028-09-10
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.